Paul G. Allen Frontiers Group

Add links
Source: Wikipedia, the free encyclopedia.

The Paul G. Allen Frontiers Group is a Seattle-based bioscience research initiative started in 2016 and funded with an initial investment of $100 million.

bioscience that are ripe for a major breakthrough, and then fund specific investigators to pursue advances.[3]

In 2021, the Allen Frontiers Group joined the Open Research Funders Group (ORFG).[4]

Allen Distinguished Investigators

The Distinguished Investigator program "awards grants of $1.5 million of three years in support of early-stage research in biology and medicine that would not otherwise be supported by traditional funding sources."[5]

External links

References

  1. ISSN 0190-8286
    . Retrieved 2023-11-07.
  2. ^ Savchuk, Katia. "Billionaire Paul Allen Pledges $100 Million To Fund Cutting-Edge Life Sciences Research". Forbes. Retrieved 2023-11-07.
  3. ^ "Microsoft pioneer invests big, again, in bioscience". Sciencemag.org. Retrieved March 24, 2016.
  4. ^ "Allen Frontiers Group Joins ORFG". Open Research Funders Group. 2021-09-29. Retrieved 2023-11-07.
  5. ^ "Frontiers Group announces 2021 Allen Distinguished Investigators". Philanthropynewsdigest.org.


This article about an organization in the United States is a stub. You can help Wikipedia by expanding it.

Stub icon

This article about a biology organization is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Paul_G._Allen_Frontiers_Group&oldid=1190958597"